Inve US ▾
AHAHR

American Healthcare REIT (AHR) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Real Estate· Aug 7, 2026

Source: earnings call transcript

Executive summary

American Healthcare REIT Q2 FY26 — Strong Performance Drives Increased Full-Year Guidance and Significant Acquisition Activity

American Healthcare REIT delivered a robust second quarter, marked by strong organic growth and significant acquisition momentum, leading to a material increase in full-year guidance. The company is actively scaling its platform, leveraging deep operator relationships and disciplined underwriting to capitalize on generational investment opportunities in the senior housing sector, while also navigating a leadership transition with Jeff Hanson assuming the CEO role.

Highlights

5
  • Total portfolio same-store NOI grew 13.2% year-over-year for the tenth consecutive quarter.

  • Normalized FFO per diluted share increased 28.6% year-over-year to $0.54 in Q2 FY26.

  • Full-year NFFO per diluted share guidance was raised to a range of $2.15 to $2.19, representing ~26% growth over 2025.

  • Net debt to EBITDA improved to 2.5x, a 0.5 turn better than Q1 FY26.

  • Closed over $1.4 billion in new acquisitions year-to-date, with an additional $800 million in the pipeline.

Concerns

2
  • Trilogy's skilled nursing occupancy stepped down 70 basis points sequentially in Q2 FY26.

  • Senior housing occupancy experienced typical first-half seasonality, with a slight pullback of 50 basis points from Q1 FY26.

Guidance & targets

CategoryTargetConfidence
Normalized FFO per diluted share
$2.15 to $2.19
high materiality
High
Total portfolio same-store NOI growth
11% to 13%
high materiality
High
Integrated senior health campuses same-store NOI growth
13% to 16%
medium materiality
High
SHOP same-store NOI growth
18% to 21%
high materiality
High
Outpatient medical same-store NOI growth
Flat to up 1%
low materiality
Medium
Triple net leased properties same-store NOI growth
2% to 3% increase
low materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Total Portfolio
Same-store NOI growth for the tenth consecutive quarter.
—13.2%4.9%—
Integrated Senior Health Campuses (Trilogy)
Set a new post-pandemic high watermark for same-store NOI margin. Occupancy held bucking usual first half seasonality, with strength in senior housing offsetting skilled nursing dip.
Same-store occupancy: 90.7%Skilled nursing occupancy (sequential change): -70 bpsSenior housing occupancy: 91.9%Senior housing occupancy (sequential change): FlatSenior housing occupancy (YoY change): +200 bpsSame-store operating expenses (sequential change): -0.9%Controllable costs (sequential change): -4.6%Quality mix: 75.5% of resident days
—16.1%5.4%21.1%
SHOP
Strong results driven by widening spread between RevPAR and ExPOR, leading to significant margin expansion. Occupancy continues to grow year-over-year.
Same-store NOI margin (YoY expansion): 242 bpsRevPAR (sequential change): +1.4%ExPOR (sequential change): -0.8%
—20.5%9.9%22.3%

AHR operating KPIs by quarter

AHR operating KPIs stated on its earnings calls, by fiscal quarter
KPI Mar 2026 Q1 FY26This call Jun 2026 Q2 FY26Change vs prior quarter
Occupancy rate Trilogy
91.2% Our ISHC segment, also known as Trilogy, delivered same-store NOI growth of 14.5%, with same-store occupancy averaging 91.2%, up roughly 220 basis points year-over-year. Source: earnings call transcript
90.7% Same-store NOI grew 16.1% year-over-year and 5.4% sequentially, while same-store occupancy averaged 90.7%, up 180 basis points from a year ago. Source: earnings call transcript
-0.5 pt

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Investment pipeline $800M Q2 FY26

Includes newly awarded deals and deals awarded in Q1 not yet closed. Expected to close most, if not all, before year-end.

Loan on properties with options to acquire $86.2M post Q2 FY26

Loan on 7 properties with an existing partner, with a defined path to near-term ownership.

Deals & partnerships

Existing regional partner Expansion with existing operators, deepening Southeast presence. $86.4M

Acquisition of 4 communities in Georgia and South Carolina.

Existing partner Expansion with existing operators. $40.5M

Acquisition of 1 community in Minnesota.

Various Opportunistic pruning of noncore assets. $22.3M

Sale of 3 noncore properties.

New regional operators Expansion into new regions (Northeast) and deepening exposure in existing regions (Southeast). $1B

Acquisition of 10 additional SHOP communities after quarter end.

Existing partner Loan on properties with options to acquire. $86.2M

Funded a loan on 7 properties with options to acquire them, with a defined path to near-term ownership.

Capital programs

Trilogy new campus development underway

Benefit:5 campuses

Five new campuses are currently in construction, part of Trilogy's ongoing development capabilities.

Trilogy villa expansions underway

Benefit:5-6 projects per year

Multi-year runway for villa expansions on existing Trilogy properties with excess land, focused on pre-leasing and derisking.

Trilogy Legacy Village (Memory Care) underway

Benefit:40-unit communities

Stand-alone memory care villages next to Trilogy main campuses, included in expansion projects.

Risks & headwinds

Skilled nursing occupancy decline Q2 FY26

70 bps sequential decline in Q2 FY26

Mitigation:Offset by strength in Trilogy's senior housing segment; focus on quality mix (75.5% of resident days) and selective payer sources.

Senior housing occupancy seasonality Q2 FY26

50 bps sequential pullback from Q1 FY26

Mitigation:Viewed as typical seasonality; starting with higher occupancy into the busiest selling season, which provides more pricing power.

Cap rate expansion risk Q3-Q4 FY25, Q1 FY26

Cap rate compression seen late last year

Mitigation:Cap rates have remained fairly static over the last several months; leveraging off-market deals and disciplined underwriting to maintain yields and acquire high-quality assets below replacement cost.

What to watch in Q3 FY26

Trilogy Occupancy & Revenue Management

next quarter
Current Senior housing occupancy 91.9% (flat QoQ), skilled nursing -70bps QoQ
Target Continued sequential growth in occupancy and effective revenue management

Why it matters

Indicates demand strength and pricing power, crucial for SHOP margin expansion and overall NOI growth.

And we're seeing the selling season now in July actually looking pretty strong. And we -- we're ahead of where we were in Q2, ahead of where we started last year at this time, and that provides more pricing power as well.

Find out whether AHR delivers this. Inve re-checks your case every morning.

Q&A highlights

What drove the deceleration in controllable costs within Trilogy, and is the sub-2% growth rate sustainable or transitory?

Gabe Willhite explained that Trilogy's team made expense management a big focus, leading to strong performance. While some seasonality exists (utilities in Midwest), the overall execution on expense control is robust and comes from multiple components, making outperformance on this front achievable.

“That team has shown time and time again that if they focus on something they can really outperform what the expectations will be.”

asked by Michael Stroyeck · answered by Gabriel Willhite

2 min read 6 chapters

Detailed narrative

Leadership Transition and Strategic Vision

Jeff Hanson, who co-founded the platform 21 years ago, has returned as CEO, emphasizing rapid scaling, disciplined growth, and strengthening the leadership team. He highlighted the company's long-standing strategy, built with Danny Prosky, and the focus on becoming the partner of choice for senior housing operators. The transition was facilitated by a decade-long succession plan, with Gabe Willhite elevated to President and COO, and Scott Estes appointed Lead Independent Director.

Operational Excellence and Margin Expansion

The company achieved double-digit same-store NOI growth for the tenth consecutive quarter, driven by strong performance in both Trilogy and SHOP segments. Trilogy set a new post-pandemic high for same-store NOI margin at 21.1%, benefiting from effective expense control (controllable costs down 4.6% sequentially) and quality mix improvement (75.5% of resident days). SHOP expanded its same-store NOI margin by 242 bps YoY to 22.3%, with RevPAR rising 1.4% and ExPOR decreasing 0.8% sequentially.

Aggressive Capital Allocation and Acquisition Strategy

AHR closed over $1.4 billion in acquisitions year-to-date, with an additional $800 million in the pipeline, none of which is reflected in current guidance. The strategy focuses on high-quality, institutional-grade assets in infill markets, often sourced off-market through existing operator relationships. Acquisitions are typically below replacement cost, with initial yields in the mid-5s to low 6s, stabilizing to 7% or above. The average age of the $2.2 billion in referenced acquisitions is 2019 vintage, significantly improving the portfolio's overall age.

Balance Sheet Strength and Funding Capacity

Net debt to EBITDA improved to 2.5x for Q2 FY26, a significant reduction from 3x in Q1 FY26 and 1.2 turns better than Q2 FY25. The company raised approximately $1.5 billion in equity capital in Q2 FY26 and subsequent, with $631 million in unsettled forward sale agreements providing a powerful funding source for the pipeline. This strong financial position, coupled with an $800 million fully available revolving credit facility, enables offensive pursuit of attractive opportunities.

Platform Enhancement and Operator Support

AHR is investing ahead of growth by adding depth in asset management, clinical oversight, and underwriting. The revenue management, analytics, and reporting tools developed with Trilogy are being extended to more SHOP operators, enhancing capabilities for partners. The company hosts innovation forums for 11 operators, fostering best practices and ensuring new acquisitions land with operators meeting AHR's standards.

Trilogy's Development Pipeline and Market Position

Trilogy continues to execute on its development plan, with 5 new campuses under construction and a multi-year runway for villa expansions and other modular additions on approximately 30 existing properties with excess land. This organic growth channel is expected to contribute to future performance, with strong pre-leasing and performance meeting underwriting expectations. Trilogy's Med Advantage rate growth was 8.4% YoY on a same-store basis, demonstrating effective optimization of payer mix.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.